A DNA Element That Regulates Expression of an Endogenous Retrovirus during F9 Cell Differentiation Is E1A Dependent

REFERENCES

• Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1989. Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system. Proc. Natl. Acad. Sci. USA 86: 4352–4356.
   PubMedGoogle Scholar
• Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62: 659–669.
   PubMed Web of Science ®Google Scholar
• Bagchi, S., R. Weinmann, and P. Raychaudhuri. 1991. The retinoblastoma protein copurifies with E2F-I, an ElA-regulated inhibitor of the transcription factor E2F. Cell 65: 1063–1072.
   PubMed Web of Science ®Google Scholar
• Boulanger, P. A., and G. E. Blair. 1991. Expression and interactions of human adenovirus oncoproteins. Biochem. J. 275: 281–299.
   PubMed Web of Science ®Google Scholar
• Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoterspecific transcription factor SP1. Science 234: 47–52.
   PubMed Web of Science ®Google Scholar
• Falzon, M., and E. L. Kuff. 1990. A variant binding sequence for transcription factor EBP-80 confers increased promoter activity on a retroviral long terminal repeat. J. Biol. Chem. 265: 13084–13090.
   PubMedGoogle Scholar
• Ferguson, B., B. Krippl, O. Andrisani, N. Jones, and H. Westphal. 1985. E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Mol. Cell. Biol. 5: 2653–2661.
   PubMedGoogle Scholar
• Flamant, F., C. C. Gurin, and J. A. Sorge. 1987. An embryonic DNA-binding protein specific for the promoter of the retrovirus long terminal repeat. Mol. Cell. Biol. 7: 3548–3553.
   PubMedGoogle Scholar
• Fiyimura, F. K., P. L. Deininger, T. Friedmann, and E. Linney. 1981. Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells. Cell 23: 809–814.
   PubMedGoogle Scholar
• Gorman, C. M., P. W.J. Rigby, and D. P. Lane. 1985. Negative regulation of viral enhancers in undifferentiated embryonic stem cells. Cell 42: 519–526.
   PubMed Web of Science ®Google Scholar
• Hen, R., E. Borrelli, and P. Chambon. 1985. Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products. Science 230: 1391–1394.
   PubMedGoogle Scholar
• Horikoshi, N., K. Maguire, A. Kralli, E. Maldonado, D. Rein- berg, and R. Weinmann. 1991. Direct interaction between adenovirus El A and the TATA-box binding protein TFIID. Proc. Natl. Acad. Sci. USA 88: 5124–5128.
   PubMedGoogle Scholar
• Howe, C. C., and G. C. Overton. 1986. Expression of the intracisternal A-particle is elevated during differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 6: 150–157.
   PubMedGoogle Scholar
• Imperiale, M. J., H.-T. Kao, L. T. Feldman, J. R. Nevins, and S. Strickland. 1984. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular ElA-like activity. Mol. Cell. Biol. 4: 867–874.
   PubMed Web of Science ®Google Scholar
• Jones, K. A., J. T. Kadonaga, P. J. Rosenfeld, T. J. Kelly, and R. Tjian. 1987. A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication. Cell 48: 79–89.
   PubMed Web of Science ®Google Scholar
• Jones, N. C., P. W.J. Rigby, and E. B. Ziff. 1988. Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. Genes Dev. 2: 267–281.
   PubMedGoogle Scholar
• Kelly, F., and H. Condamine. 1982. Tumor viruses and early mouse embryos. Biochim. Biophys. Acta 651: 105–141.
   PubMedGoogle Scholar
• Lamb, B. T., K. Satyamoorthy, L. Li, D. Softer, and C. C. Howe. 1991. CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity. Gene Expression 1: 185–196.
   PubMedGoogle Scholar
• Lee, K. A. W., T. Y. Hai, L. SivaRaman, B. Thimmappaya, H. C. Hurst, N. C. Jones, and M. Green. 1987. A cellular protein, activating transcription factor, activates transcription of multiple ElA-inducible adenovirus early promoters. Proc. Natl. Acad. Sci. USA 84: 8355–8359.
   PubMed Web of Science ®Google Scholar
• Lee, W. S., C. C. Kao, G. O. Bryant, X. Liu, and A. J. Berk. 1991. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell 67: 365–376.
   PubMedGoogle Scholar
• Leonardo, M. J., L. Staudt, P. Robbins, A. Kuang, R. C. Mulligan, and D. Baltimore. 1989. Repression of the IgH enhancer in teratocarcinoma cells with a novel octamer factor. Science 243: 544–546.
   PubMedGoogle Scholar
• Lillie, J. W., and M. R. Green. 1989. Transcription activation by the adenovirus E1A protein. Nature (London) 338: 39–44.
   PubMedGoogle Scholar
• Lin, Y.-S., and M. R. Green. 1988. Interaction of a common cellular transcription factor, ATF, with regulatory elements in both Ela- and cyclic AMP-inducible promoters. Proc. Natl. Acad. Sci. USA 85: 3396–3400.
   PubMed Web of Science ®Google Scholar
• Linney, E., and S. Donerly. 1983. DNA fragments from F9 PyEC mutants increase expression of heterologous genes in transfected F9 cells. Cell 35: 693–699.
   PubMed Web of Science ®Google Scholar
• Liu, F., and M. R. Green. 1990. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus Ela protein. Cell 61: 1217–1224.
   PubMed Web of Science ®Google Scholar
• Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15: 5490.
   PubMed Web of Science ®Google Scholar
• Miyazaki, J.-L, E. Appella, and K. Ozato. 1986. Negative regulation of the major histocompatibility class I gene in undifferentiated embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 83: 9537–9541.
   PubMedGoogle Scholar
• Montminy, M. R., K. A. Sevarino, J. A. Wagner, G. Mandel, and R. H. Goodman. 1986. Identification of a cyclic-AMP- responsive element within the rat somatostatin gene. Proc. Natl. Acad. Sci. USA 83: 6682–6686.
   PubMed Web of Science ®Google Scholar
• Moran, E., and M. B. Mathews. 1987. Multiple functional domains in the adenovirus E1A gene. Cell 48: 177–178.
   PubMed Web of Science ®Google Scholar
• Moran, E., B. Zerler, T. M. Harrison, and M. B. Mathews. 1986. Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol. Cell. Biol. 6: 3470–3480.
   PubMedGoogle Scholar
• Offringa, R., S. Gebel, H. van Dam, M. Timmers, A. Smits, R. Zwart, B. Stein, J. L. Bos, A. Van der Eb, and P. Herrlich. 1990. A novel function of the transforming domain of E1A: repression of AP-1 activity. Cell 62: 527–538.
   PubMedGoogle Scholar
• Piette, J., and M. Yaniv. 1987. Two different factors bind to the a-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J. 6: 1331–1337.
   PubMedGoogle Scholar
• Rochette-Egly, C., C. Fromental, and P. Chambon. 1990. General repression of enhancer activity by the adenovirus-2 E1A proteins. Genes Dev. 4: 137–150.
   PubMedGoogle Scholar
• Scheidereit, C., and M. Beato. 1984. Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory element of mouse mammary tumor virus. Proc. Natl. Acad. Sci. USA 81: 3029–3033.
   PubMedGoogle Scholar
• Scholer, H. R., T. Ciesolka, and P. Gruss. 1991. A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells. Cell 66: 291–304.
   PubMed Web of Science ®Google Scholar
• Schrier, P. I., R. Bernard, R. T.M. J. Vaessen, A. Houweling, and A. Van der Eb. 1983. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature (London) 305: 771–776.
   PubMed Web of Science ®Google Scholar
• Shirayoshi, Y., J.-I. Mirazaki, P. A. Burke, K. Hamada, E. Appella, and K. Ozato. 1987. Binding of multiple nuclear factors to the 5′ upstream regulatory element of the murine major histocompatibility class I gene. Mol. Cell. Biol. 7: 4542–4548.
   PubMedGoogle Scholar
• Singh, H., R. G. Clerc, and J. H. Lebowitz. 1989. Molecular cloning of sequence-specific DNA binding proteins using recognition site probes. Bio/Techniques 7: 252–261.
   PubMedGoogle Scholar
• Stein, R. W., M. Corrigan, P. Yaciuk, J. Whelan, and E. Moran. 1990. Analysis of ElA-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J. Virol. 64: 4421–4427.
   PubMedGoogle Scholar
• Stein, R. W., and J. Whelan. 1989. Insulin gene enhancer activity is inhibited by adenovirus 5 E1A gene products. Mol. Cell. Biol. 9: 4531–4534.
   PubMedGoogle Scholar
• Strickland, S., K. K. Smith, and K. R. Marotti. 1980. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21: 347–355.
   PubMed Web of Science ®Google Scholar
• Van Dam, H., R. Offringa, I. Meyer, B. Stein, A. M. Smits, P. Herrlich, J. L. Bos, and A. J. Van der Eb. 1990. Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family. Mol. Cell. Biol. 10: 5857–5864.
   PubMedGoogle Scholar
• Velcich, A., F. G. Kern, C. Basilico, and E. B. Ziff. 1986. Adenovirus Ela proteins repress expression from polyomavirus early and late promoters. Mol. Cell. Biol. 6: 4019–4025.
   PubMedGoogle Scholar
• Wada, T., H. Watanabe, Y. Usuda, and H. Handa. 1991. Different biological activities of the hetero- and homodimers formed by the 47- and 43-kilodalton proteins of transcription factor ATF/E4TF3. J. Virol. 65: 557–564.
   PubMedGoogle Scholar
• Wasylyk, B., J. L. Imler, B. Chatton, C. Schatz, and C. Wasylyk. 1988. Negative and positive factors determine the activity of the polyoma virus enhancer a domain in undifferentiated and differentiated cell types. Proc. Natl. Acad. Sci. USA 85: 7952–7956.
   PubMedGoogle Scholar
• Watanabe, H., T. Imai, P. A. Sharp, and H. Handa. 1988. Identification of two transcription factors that bind to specific elements in the promoter of the adenovirus early-region 4. Mol. Cell. Biol. 8: 1290–1300.
   PubMedGoogle Scholar
• Weeks, W. L., and N. C. Jones. 1983. E1A control of gene expression is mediated by sequences 5′ to the transcriptional starts of the early viral genes. Mol. Cell. Biol. 3: 1222–1234.
   PubMed Web of Science ®Google Scholar
• Weiher, H., M. Konig, and P. Gruss. 1983. Multiple point mutations affecting the simian virus 40 enhancer. Science 219: 626–631.
   PubMed Web of Science ®Google Scholar
• Whelan, J., D. Poon, P. A. Weil, and R. Stein. 1989. Pancreatic β-cell-type-specific expression of the rat insulin II gene is controlled by positive and negative cellular transcriptional elements. Mol. Cell. Biol. 9: 3253–3259.
   PubMedGoogle Scholar
• Xin, J.-H., A. Cowie, P. Lachance, and J. A. Hassell. 1992. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6: 481–496.
   PubMedGoogle Scholar
• Yamamoto, K. K., G. A. Gonzalez, W. H. Biggs III, and M. R. Montminy. 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature (London) 334: 494–498.
   PubMedGoogle Scholar
• Young, K. S., R. Weigel, S. Hiebert, and J. R. Nevins. 1989. Adenovirus ElA-mediated negative control of genes activated during F9 differentiation. Mol. Cell. Biol. 9: 3109–3113.
   PubMedGoogle Scholar